Valuation for Perspective Therapeutics, Common Stock (id:170 CATX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -1.68 |
|
|
| Forward P/E | -3.70 |
|
|
| Price to sales | 173.64 |
|
|
| Price to book | 3.00 |
|
|
| Enterprise to revenue | 4.35 |
|
|
| Enterprise to ebitda | 3.00 |
|
|